Using breast magnetic resonance imaging (MRI) screenings among targeted, high-risk, underserved women significantly decreased diagnostic cost and increased patient compliance rates with follow-up compared to using general ...
Sep 20, 2011
0
0
More than one-third of counties in the Unites States are located more than 50 miles from the nearest gynecologic oncologist, making access to specialty care for ovarian and other gynecologic cancers difficult for nearly 15 ...
Jun 11, 2015
0
284
Uterine sarcoma - a potentially aggressive type of cancer that forms in tissues in the uterus - was found in 0.22 % of women following a hysterectomy for benign conditions, a new large-scale study by the University of Michigan ...
Feb 19, 2015
0
3
(Medical Xpress)—The addition of chemotherapy to post-surgical radiation treatment is not effective in treating vulvar cancer, according to Magee-Womens Hospital of UPMC research presented this week in San Francisco at ...
Sep 19, 2014
0
0
A study by researchers at the Herbert Irving Comprehensive Cancer Center (HICCC) at NewYork-Presbyterian/Columbia University Medical Center, recently e-published ahead of print by the Journal of Clinical Oncology, suggests ...
Nov 8, 2012
0
0
Two Swedish women received new uteruses at the weekend in the world's first mother-to-daughter uterine transplants aimed at helping them have babies, Gothenburg University announced on Tuesday.
Sep 18, 2012
0
0
Women with advanced ovarian cancer often face grim statistics, with less than half surviving for five years after their diagnosis. However, a new study suggests that so-called "maintenance therapy" with a targeted cancer ...
Mar 26, 2021
0
2
A COVID-19 diagnosis can lead to potentially life-threatening treatment delays for women with gynecological cancers, a new study finds. That's especially true for non-white patients, the researchers said.
Mar 21, 2022
0
5
Evaluating its change over time, CA-125, the protein long-recognized for predicting ovarian cancer recurrence, now shows promise as a screening tool for early-stage disease, according to researchers at The University of Texas ...
Aug 26, 2013
0
0
A drug already approved for treating kidney cancer was successful at delaying the return of advanced ovarian cancer by an average of nearly six months, a clinical study released Saturday found.
Jun 1, 2013
0
1
